Widefield Imaging Systems Market

Instrument is projected to lead at 71.0% share in 2026, followed by Diabetic Retinopathy as set to secure 33.6% share of indication in 2026. Diabetic retinopathy prevalence growth is expected to push widefield imaging procurement as screening programs expand across hospital and clinic settings.